Zota Health Care Allots 1.07 Lakh Equity Shares on Warrant Conversion

Zota Health Care Limited has approved the allotment of 1,07,556 fully paid-up equity shares, each with a face value of ₹10, at an issue price of ₹509 per share. This allotment follows the conversion o...

Zota Health Care Limited has approved the allotment of 1,07,556 fully paid-up equity shares, each with a face value of ₹10, at an issue price of ₹509 per share. This allotment follows the conversion of an equivalent number of warrants, which were issued on a preferential basis to the Non-Promoter Group. The company received ₹4,10,59,503.00 (Rupees Four Crores Ten Lakhs Fifty Nine Thousand Five Hundred and Three) from 03 warrant holders, representing 75% of the warrant exercise money. The Board of Directors approved this allotment in their meeting held on Friday, January 02, 2026. The newly allotted equity shares will rank pari passu with the existing equity shares of the company. Consequent to this allotment, the paid-up equity capital of Zota Health Care Limited has increased from ₹33,77,39,010 (comprising 3,37,73,901 equity shares) to ₹33,88,14,570 (comprising 3,38,81,457 equity shares). The announcement also provides a reconciliation of outstanding warrants, showing that after this allotment, 7,51,130 warrants remain outstanding. The three investors who were allotted shares are Alka Rajesh Agrawal (44,204 shares), Prafull Rai (22,102 shares), and Rajnibhai Virchandbhai Shah (41,250 shares), all categorized under Non-Promoter.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Zota Health Care LImited in the news today?

Zota Health Care LImited (ZOTA) is in the news due to the allotment of equity shares upon conversion of warrants signifies an increase in the company's capital base and potentially reflects investor confidence, which is a positive development.

Equity FundraisingOther Corporate Actions
Zota Health Care LImitedZOTAhttps://prysm.fi/v2/analyze/ZOTA

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Zota Health Care Allots 1.07 Lakh Equity Shares on Warrant Conversion

January 2, 2026, 10:14 AM

AI Sentiment Analysis

Top Queries to Ask About Zota Health Care LImited

More Details on This News

Zota Health Care Limited has approved the allotment of 1,07,556 fully paid-up equity shares, each with a face value of ₹10, at an issue price of ₹509 per share. This allotment follows the conversion of an equivalent number of warrants, which were issued on a preferential basis to the Non-Promoter Group.

The company received ₹4,10,59,503.00 (Rupees Four Crores Ten Lakhs Fifty Nine Thousand Five Hundred and Three) from 03 warrant holders, representing 75% of the warrant exercise money. The Board of Directors approved this allotment in their meeting held on Friday, January 02, 2026.

The newly allotted equity shares will rank pari passu with the existing equity shares of the company. Consequent to this allotment, the paid-up equity capital of Zota Health Care Limited has increased from ₹33,77,39,010 (comprising 3,37,73,901 equity shares) to ₹33,88,14,570 (comprising 3,38,81,457 equity shares).

The announcement also provides a reconciliation of outstanding warrants, showing that after this allotment, 7,51,130 warrants remain outstanding. The three investors who were allotted shares are Alka Rajesh Agrawal (44,204 shares), Prafull Rai (22,102 shares), and Rajnibhai Virchandbhai Shah (41,250 shares), all categorized under Non-Promoter.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Zota Health Care LImited

Discover more trending news on Prysm

View All